Boundless Bio (BOLD) – Downgrades
-
Evercore ISI Downgrades Audentes Therapeutics (BOLD) to In Line Following Acquisition
-
JPMorgan Downgrades Audentes Therapeutics (BOLD) to Neutral Following Acquisition
-
-
-
-
-
-
-
-
-
-
-
-
Back to BOLD Stock Lookup